VINC - Vincerx Pharma Inc
IEX Last Trade
0.82
-0.019 -2.317%
Share volume: 221,244
Last Updated: Fri 30 Aug 2024 09:28:16 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.84
-0.02
-2.27%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
9.36%
1 Month
33.25%
3 Months
18.79%
6 Months
-78.42%
1 Year
18.84%
2 Year
-46.05%
Key data
Stock price
$0.82
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.51 - $9.37
52 WEEK CHANGE
$0.15
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: vincerx.com
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: vincerx.com
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
Recent news